The PROTEMBO Trial
The goal of this prospective, multi-center, randomized, controlled study is to compare
the safety and efficacy of the ProtEmbo Cerebral Embolic Protection device to a hybrid
control (no embolic protection device ('No Device') and the Sentinel device) in subjects
with...
Age: 18 years - 66+
Gender: All
Evolut™ EXPAND TAVR II Pivotal Trial
Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR
System to include patients with moderate, AS.
Age: 65 years - 66+
Gender: All
Optimize PRO Study
The purpose of this study is to collect clinical evidence on valve performance and procedural
outcomes associated with an "optimized" TAVR care pathway and post-TAVR conduction
disturbance pathway while using the Evolut™ PRO and Evolut™ PRO+ devices.
The purpose...
Age: Birth - 66+
Gender: All